These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 8816381)

  • 1. Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells.
    Ardavín C; Waanders G; Ferrero I; Anjuère F; Acha-Orbea H; MacDonald HR
    J Immunol; 1996 Oct; 157(7):2789-94. PubMed ID: 8816381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets.
    Waanders GA; Lees RK; Held W; MacDonald HR
    Eur J Immunol; 1995 Sep; 25(9):2632-7. PubMed ID: 7589137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages.
    Morishima C; Norby-Slycord C; McConnell KR; Finch RJ; Nelson AJ; Farr AG; Pullen AM
    J Immunol; 1994 Dec; 153(11):5091-103. PubMed ID: 7963568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
    Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
    Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the avidity of TCR interactions with a superantigenic ligand affect negative selection but do not allow positive selection.
    Chervonsky AV; Golovkina TV; Ross SR; Janeway CA
    J Immunol; 1995 Dec; 155(11):5115-23. PubMed ID: 7594520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of Mtv loci in MHC class II-positive thymic stromal cells.
    Moore NC; Anderson G; McLoughlin DE; Owen JJ; Jenkinson EJ
    J Immunol; 1994 May; 152(10):4826-31. PubMed ID: 8176205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologic expression of two superantigens in the BDF1 mouse.
    Gollob KJ; Palmer E
    J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro negative selection of viral superantigen-reactive thymocytes by thymic dendritic cells.
    Ferrero I; Anjuère F; MacDonald HR; Ardavín C
    Blood; 1997 Sep; 90(5):1943-51. PubMed ID: 9292528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene.
    Xu L; Wrona TJ; Dudley JP
    Virology; 1997 Sep; 236(1):54-65. PubMed ID: 9299617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
    Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
    J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delay in expression of a mammary tumor provirus is responsible for defective clonal deletion during postnatal period.
    Niimi N; Wajjwalku W; Ando Y; Tomida S; Takeuchi M; Ueda M; Kaneda T; Yoshikai Y
    Eur J Immunol; 1994 Feb; 24(2):488-91. PubMed ID: 8299700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Mtv-7 sag gene in vivo using a retroviral vector results in selective inactivation of superantigen reactive T cells.
    Kang J; Ido E; Pawling J; Beutner U; Huber BT; Hozumi N
    J Immunol; 1994 Feb; 152(3):1039-46. PubMed ID: 8301116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Requirement of class II and membrane proximal region of mouse mammary tumor virus superantigen (Mtv SAG) in Mtv7 SAG presentation].
    Okamoto M; Kimura S; Katagiri M
    Hokkaido Igaku Zasshi; 1998 May; 73(3):205-14. PubMed ID: 9719947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of peripheral V beta 14+ T cells by Mtv-2-encoded viral superantigen preceded by blastogenesis and DNA synthesis but not by specific expansion.
    Nakano H; Yoshimoto T; Nariuchi H; Kakiuchi T; Matsuzawa A
    Cell Immunol; 1996 Mar; 168(2):281-90. PubMed ID: 8640876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an endogenous mammary tumor virus involved in the clonal deletion of V beta 2 T cells.
    Jouvin-Marche E; Marche PN; Six A; Liebe-Gris C; Voegtle D; Cazenave PA
    Eur J Immunol; 1993 Nov; 23(11):2758-64. PubMed ID: 8223851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors on T cells escaping superantigen-mediated deletion lack special beta-chain junctional region structural characteristics.
    Pullen AM; Bogatzki LY
    J Immunol; 1996 Mar; 156(5):1865-72. PubMed ID: 8596038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
    Maillard I; Erny K; Acha-Orbea H; Diggelmann H
    Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance.
    Modlin CS; Todd GT; Cohen TD; Fairchild RL
    Cell Immunol; 1995 Sep; 164(2):217-26. PubMed ID: 7656330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse mammary tumor virus superantigens require N-linked glycosylation for effective presentation to T cells.
    McMahon CW; Bogatzki LY; Pullen AM
    Virology; 1997 Feb; 228(2):161-70. PubMed ID: 9123822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.